NO20052124L - Nye 1,4-diazabisykloalkanderivater, deres fremstilling og anvendelse - Google Patents
Nye 1,4-diazabisykloalkanderivater, deres fremstilling og anvendelseInfo
- Publication number
- NO20052124L NO20052124L NO20052124A NO20052124A NO20052124L NO 20052124 L NO20052124 L NO 20052124L NO 20052124 A NO20052124 A NO 20052124A NO 20052124 A NO20052124 A NO 20052124A NO 20052124 L NO20052124 L NO 20052124L
- Authority
- NO
- Norway
- Prior art keywords
- disorders
- enantiomers
- compounds
- nervous system
- disease
- Prior art date
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 7
- 208000035475 disorder Diseases 0.000 abstract 4
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 2
- 210000003169 central nervous system Anatomy 0.000 abstract 2
- 230000001713 cholinergic effect Effects 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000017701 Endocrine disease Diseases 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 210000001428 peripheral nervous system Anatomy 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000016160 smooth muscle contraction Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200201456 | 2002-09-30 | ||
| DKPA200201738 | 2002-11-11 | ||
| PCT/DK2003/000639 WO2004029053A1 (en) | 2002-09-30 | 2003-09-29 | Novel 1,4-diazabicycloalkane derivatives, their preparation and use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20052124D0 NO20052124D0 (no) | 2005-04-29 |
| NO20052124L true NO20052124L (no) | 2005-06-29 |
Family
ID=34828377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20052124A NO20052124L (no) | 2002-09-30 | 2005-04-29 | Nye 1,4-diazabisykloalkanderivater, deres fremstilling og anvendelse |
Country Status (11)
| Country | Link |
|---|---|
| JP (1) | JP4711391B2 (enExample) |
| KR (1) | KR20050062575A (enExample) |
| CN (1) | CN1326857C (enExample) |
| BR (1) | BR0314183A (enExample) |
| IL (1) | IL166821A (enExample) |
| IS (1) | IS7829A (enExample) |
| MX (1) | MXPA05003344A (enExample) |
| NO (1) | NO20052124L (enExample) |
| PT (1) | PT1551835E (enExample) |
| RU (1) | RU2323218C2 (enExample) |
| SI (1) | SI1551835T1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2368614C2 (ru) * | 2004-02-04 | 2009-09-27 | НьюроСёрч А/С | Диазабициклические арильные производные в качестве модуляторов холинергических рецепторов |
| JO3019B1 (ar) * | 2006-04-19 | 2016-09-05 | Janssen Pharmaceutica Nv | ثلاثي مستبدل 4،2،1-ثلاثي زولات |
| MX2008014887A (es) * | 2006-05-30 | 2008-12-05 | Neurosearch As | Nuevos derivados de 1,4-diaza-biciclo[3.2.2]nonil oxadiazolilo y su uso medico. |
| US8492378B2 (en) | 2006-08-03 | 2013-07-23 | Takeda Pharmaceutical Company Limited | GSK-3β inhibitor |
| EP2121688A1 (en) * | 2007-02-15 | 2009-11-25 | Argenta Discovery Ltd | Heterocyclic derivatives as m3 muscarinic receptors |
| IN2014KN01075A (enExample) | 2011-11-18 | 2015-10-09 | Heptares Therapeutics Ltd | |
| GB201404922D0 (en) | 2014-03-19 | 2014-04-30 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201513743D0 (en) | 2015-08-03 | 2015-09-16 | Heptares Therapeutics Ltd | Muscarinic agonists |
| GB201519352D0 (en) | 2015-11-02 | 2015-12-16 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| CN108697709A (zh) * | 2015-12-10 | 2018-10-23 | Ptc医疗公司 | 用于治疗亨廷顿病的方法 |
| CN108727293B (zh) * | 2016-09-18 | 2021-05-11 | 广西师范大学 | 1，2，8-氧代二氮杂环壬-9-酮衍生物及其合成方法 |
| GB201617454D0 (en) | 2016-10-14 | 2016-11-30 | Heptares Therapeutics Limited | Pharmaceutical compounds |
| GB201810239D0 (en) | 2018-06-22 | 2018-08-08 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201819961D0 (en) | 2018-12-07 | 2019-01-23 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201819960D0 (en) | 2018-12-07 | 2019-01-23 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB202020191D0 (en) | 2020-12-18 | 2021-02-03 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ226000A (en) * | 1987-09-10 | 1991-06-25 | Merck Sharp & Dohme | Oxadiazolyl-azabicycloheptanes and pharmaceutical compositions |
| DE69416869T2 (de) * | 1993-12-29 | 1999-07-01 | Pfizer Inc., New York, N.Y. | Diazabicyclische neurokinin antagonisten |
| US5478939A (en) * | 1994-07-20 | 1995-12-26 | American Cyanamid Company | (R,R) and (S,S) 2,5-diazabicyclo [2,2,1]heptane derivatives |
| FR2786770B1 (fr) * | 1998-12-04 | 2001-01-19 | Synthelabo | Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique |
| PL352432A1 (en) * | 1999-07-09 | 2003-08-25 | Ortho Mc Neil Pharmaceutical | Neurothrophic pyrolydines and piperidines, their affinite composition and methods of using them |
| FR2804430B1 (fr) * | 2000-01-28 | 2002-03-22 | Sanofi Synthelabo | Derives de 4-heteroaryl-1,4-diazabicyclo[3.2.2] nonane, leur preparation et leur application en therapeutique |
| FR2809731B1 (fr) * | 2000-05-31 | 2002-07-19 | Sanofi Synthelabo | Derives de 1,4-diazabicyclo-[3.2.2] nonane-pheylisoxazole, leur preparation et leur application en therapeutique |
| FR2809732B1 (fr) * | 2000-05-31 | 2002-07-19 | Sanofi Synthelabo | DERIVES DE 4(-2-PHENYLTHIAZOL-5-yl)-1,4-DIAZABICYCLO-[3.2.2] NONANE, LEUR PREPARATION ET LEUR APPLICATION ENTHERAPEUTIQUE |
| US20020086871A1 (en) * | 2000-12-29 | 2002-07-04 | O'neill Brian Thomas | Pharmaceutical composition for the treatment of CNS and other disorders |
| FR2832713B1 (fr) * | 2001-11-23 | 2004-02-13 | Sanofi Synthelabo | Derives de 4-(1,3,4-thiadiazol-2-yl)-1,4-diazabicyclo[3.2.2] nonane, leur preparation et leur application en therapeutique |
-
2003
- 2003-09-29 KR KR1020057005508A patent/KR20050062575A/ko not_active Ceased
- 2003-09-29 CN CNB038232626A patent/CN1326857C/zh not_active Expired - Fee Related
- 2003-09-29 MX MXPA05003344A patent/MXPA05003344A/es active IP Right Grant
- 2003-09-29 PT PT03798094T patent/PT1551835E/pt unknown
- 2003-09-29 RU RU2005105048/04A patent/RU2323218C2/ru not_active IP Right Cessation
- 2003-09-29 SI SI200330715T patent/SI1551835T1/sl unknown
- 2003-09-29 JP JP2004538781A patent/JP4711391B2/ja not_active Expired - Fee Related
- 2003-09-29 BR BR0314183-7A patent/BR0314183A/pt not_active Application Discontinuation
-
2005
- 2005-02-10 IL IL166821A patent/IL166821A/en not_active IP Right Cessation
- 2005-04-28 IS IS7829A patent/IS7829A/is unknown
- 2005-04-29 NO NO20052124A patent/NO20052124L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP4711391B2 (ja) | 2011-06-29 |
| JP2006503062A (ja) | 2006-01-26 |
| MXPA05003344A (es) | 2005-11-23 |
| PT1551835E (pt) | 2007-03-30 |
| NO20052124D0 (no) | 2005-04-29 |
| CN1684965A (zh) | 2005-10-19 |
| CN1326857C (zh) | 2007-07-18 |
| IL166821A0 (en) | 2006-01-15 |
| KR20050062575A (ko) | 2005-06-23 |
| RU2005105048A (ru) | 2005-11-20 |
| IS7829A (is) | 2005-04-28 |
| IL166821A (en) | 2009-06-15 |
| RU2323218C2 (ru) | 2008-04-27 |
| BR0314183A (pt) | 2005-08-09 |
| HK1081954A1 (en) | 2006-05-26 |
| SI1551835T1 (sl) | 2007-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20052124L (no) | Nye 1,4-diazabisykloalkanderivater, deres fremstilling og anvendelse | |
| DK1551835T3 (da) | Hidtil ukendte 1,4-diazabicycloalkanderivater, deres fremstilling og anvendelse | |
| EP1416933B8 (en) | Substituted piperidines as modulators of the melanocortin receptor | |
| NO20071660L (no) | Nye pyridinonderivater og deres anvendelse som positive allosteriske modulatorer av MGLUR2-reseptorer | |
| WO2004007481A3 (en) | Substituted amine derivatives and methods of use in the treatment of angiogenesis relates disorders | |
| WO2005080343A3 (en) | 3-substituted 1,5-diphenylpyrazole derivatives useful as cb1 modulators | |
| PL370381A1 (en) | Substituted piperazines as modulators of the melanocortin receptor | |
| JP2017039740A (ja) | Ｌｓｄ１のアリールシクロプロピルアミンをベースとしたデメチラーゼ阻害剤およびそれらの医学的使用 | |
| CA2379445A1 (en) | Lactams substituted by cyclic succinates as inhibitors of a.beta. protein production | |
| WO2004014881A3 (en) | '1,2,4'oxadiazoles as modulators of metabotropic glutamate receptor-5 | |
| EA200600811A1 (ru) | НОВЫЕ ПРОИЗВОДНЫЕ ТЕТРАГИДРОСПИРО {ПИПЕРИДИН-2,7'-ПИРРОЛО [3,2-b]ПИРИДИНА} И НОВЫЕ ПРОИЗВОДНЫЕ ИНДОЛА, ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАССТРОЙСТВ, СВЯЗАННЫХ С 5-HT-РЕЦЕПТОРОМ | |
| WO2003048164A3 (en) | Adenosine a2a receptor antagonists | |
| WO2004026248A3 (en) | Octahydro-2-h-naphtho[1,2-f] indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators | |
| WO2002068406A3 (en) | Substituted amine derivatives and their use for the treatment of angiogenesis | |
| MXPA04005209A (es) | Antagonistas del receptor de adenosina a2a. | |
| TW200502221A (en) | Novel lactams and uses thereof | |
| MY140835A (en) | Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists | |
| MXPA05010883A (es) | Derivados de amina ciclica y su uso en el tratamiento de trastornos inflamatorios relacionados mediados por bradiquinina. | |
| CA2420177A1 (en) | Quinazoline derivatives as alpha-1 adrenergic antagonists | |
| WO2006067428A3 (en) | 1, 2-diphenyl-imidazole derivatives and their use as cb1 receptor ligands | |
| WO2006053039A3 (en) | Hydroxybenzoate salts of metanicotine compounds | |
| TW200509933A (en) | Therapeutic agents | |
| CA2354606A1 (en) | Azabicycloalkane derivatives and therapeutic uses thereof | |
| WO2003072572A8 (en) | Beta3-adrenergic receptor agonists | |
| NZ533358A (en) | 3,4-Dihydro-1H-isoquinolin-2-yl-derivatives for use as NK2 receptor antagonists |